Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Apple

Showing results (241-250 of 457) with videos related to

Pageof 46
Sort By:
The American Journal of Cardiology|April 9, 2015
Multiple biomarkers including cardiac troponins T and I measured by high-sensitivity assays, as predictors of long-term mortality in patients with chronic renal failure who underwent dialysisPeter E Hickman, Darryl McGill, Julia M Potter, et al.
Journal of Shoulder and Elbow Surgery|October 20, 2001
Acromial morphotype in the young asymptomatic athletic shoulderK P Speer, D C Osbahr, B J Montella, et al.
Clinical Chemistry|June 29, 2002
Release characteristics of cardiac biomarkers and ischemia-modified albumin as measured by the albumin cobalt-binding test after a marathon raceFred S Apple, Heidi E Quist, Angela P Otto, et al.
Circulation|April 2, 2019
Clinical Features and Outcomes of Emergency Department Patients With High-Sensitivity Cardiac Troponin I Concentrations Within Sex-Specific Reference IntervalsYader Sandoval, Stephen W Smith, Anne Sexter, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|June 15, 1995
Cardiac troponin, CK-MB and myoglobin for the early detection of acute myocardial infarction and monitoring of reperfusion following thrombolytic therapyF S Apple, E Voss, L Lund, et al.
Scandinavian Journal of Clinical and Laboratory Investigation. Supplementum|July 2, 1999
Proposals from IFCC Committee on Standardization of Markers of Cardiac Damage (C-SMCD): recommendations on use of biochemical markers of cardiac damage in acute coronary syndromesM Panteghini, F S Apple, R H Christenson, et al.
Scandinavian Journal of Clinical and Laboratory Investigation. Supplementum|July 2, 1999
Proposals from the IFCC Committee on Standardization of Markers of Cardiac Damage (C-SMCD): strategies and concepts on standardization of cardiac marker assaysF Dati, M Panteghini, F S Apple, et al.
Clinical Chemistry|March 1, 1997
Cardiac troponin T composition in normal and regenerating human skeletal muscleG S Bodor, L Survant, E M Voss, et al.
Clinical Chemistry|July 26, 2003
Plasma 99th percentile reference limits for cardiac troponin and creatine kinase MB mass for use with European Society of Cardiology/American College of Cardiology consensus recommendationsFred S Apple, Heidi E Quist, Patrick J Doyle, et al.
Clinical Chemistry|September 11, 1998
Cardiac troponin T isoforms expressed in renal diseased skeletal muscle will not cause false-positive results by the second generation cardiac troponin T assay by Boehringer MannheimV Ricchiuti, E M Voss, A Ney, et al.
Pageof 46

Showing results (241-250 of 457) with videos related to

Sort By:
Pageof 46
The American Journal of Cardiology|April 9, 2015
Multiple biomarkers including cardiac troponins T and I measured by high-sensitivity assays, as predictors of long-term mortality in patients with chronic renal failure who underwent dialysisPeter E Hickman, Darryl McGill, Julia M Potter, et al.
Journal of Shoulder and Elbow Surgery|October 20, 2001
Acromial morphotype in the young asymptomatic athletic shoulderK P Speer, D C Osbahr, B J Montella, et al.
Clinical Chemistry|June 29, 2002
Release characteristics of cardiac biomarkers and ischemia-modified albumin as measured by the albumin cobalt-binding test after a marathon raceFred S Apple, Heidi E Quist, Angela P Otto, et al.
Circulation|April 2, 2019
Clinical Features and Outcomes of Emergency Department Patients With High-Sensitivity Cardiac Troponin I Concentrations Within Sex-Specific Reference IntervalsYader Sandoval, Stephen W Smith, Anne Sexter, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|June 15, 1995
Cardiac troponin, CK-MB and myoglobin for the early detection of acute myocardial infarction and monitoring of reperfusion following thrombolytic therapyF S Apple, E Voss, L Lund, et al.
Scandinavian Journal of Clinical and Laboratory Investigation. Supplementum|July 2, 1999
Proposals from IFCC Committee on Standardization of Markers of Cardiac Damage (C-SMCD): recommendations on use of biochemical markers of cardiac damage in acute coronary syndromesM Panteghini, F S Apple, R H Christenson, et al.
Scandinavian Journal of Clinical and Laboratory Investigation. Supplementum|July 2, 1999
Proposals from the IFCC Committee on Standardization of Markers of Cardiac Damage (C-SMCD): strategies and concepts on standardization of cardiac marker assaysF Dati, M Panteghini, F S Apple, et al.
Clinical Chemistry|March 1, 1997
Cardiac troponin T composition in normal and regenerating human skeletal muscleG S Bodor, L Survant, E M Voss, et al.
Clinical Chemistry|July 26, 2003
Plasma 99th percentile reference limits for cardiac troponin and creatine kinase MB mass for use with European Society of Cardiology/American College of Cardiology consensus recommendationsFred S Apple, Heidi E Quist, Patrick J Doyle, et al.
Clinical Chemistry|September 11, 1998
Cardiac troponin T isoforms expressed in renal diseased skeletal muscle will not cause false-positive results by the second generation cardiac troponin T assay by Boehringer MannheimV Ricchiuti, E M Voss, A Ney, et al.
Pageof 46